TMEFF1 and ovarian carcinoma: The expression of TMEFF1 mRNA was significantly increased in cervical cancer, colorectal cancer, esophageal cancer, gastric cancer, head and neck cancer, kidney cancer, lung cancer, myeloma, ovarian cancer, pancreatic cancer, prostate cancer and sarcoma but decreased in brain and CNS cancer (Fig. 1A).